Intervention Protocol

You have free access to this content

Intravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosis

  1. Nora Fernández Liguori1,*,
  2. Juan Ignacio Rojas2,
  3. Diana S Klajn3,
  4. Agustín Ciapponi4

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 19 JUL 2013

DOI: 10.1002/14651858.CD010601


How to Cite

Fernández Liguori N, Rojas JI, Klajn DS, Ciapponi A. Intravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD010601. DOI: 10.1002/14651858.CD010601.

Author Information

  1. 1

    Hospital Enrique Tornú, Multiple Sclerosis Clinic, Neurology Section, Buenos Aires, Argentina

  2. 2

    Hospital Italiano Buenos Aires, Neurology Department, Buenos Aires, Buenos Aires, Argentina

  3. 3

    Hospital Tornu, Academic and Research Department, Buenos Aires, Argentina

  4. 4

    Southern American Branch of the Iberoamerican Cochrane Centre, Argentine Cochrane Centre IECS, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Capital Federal, Argentina

*Nora Fernández Liguori, Multiple Sclerosis Clinic, Neurology Section, Hospital Enrique Tornú, Combatiente de Malvinas 3002, Buenos Aires, 1427, Argentina. nfliguori@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 19 JUL 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to evaluate if IVIG prevent relapses during pregnancy and postpartum period in patients with relapsing-remitting MS.